Skip to main content
Actinium Pharmaceuticals, Inc. (FRA:7AY1)
Germany flag Germany · Delayed Price · Currency is EUR
1.214
-0.036 (-2.88%)
Last updated: Dec 5, 2025, 8:04 AM CET

Actinium Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Other Revenue
0.09-0.081.031.14-
Upgrade
Revenue
0.09-0.081.031.14-
Upgrade
Revenue Growth (YoY)
11.11%--92.14%-9.96%--
Upgrade
Gross Profit
0.09-0.081.031.14-
Upgrade
Selling, General & Admin
15.7912.0813.33128.086.31
Upgrade
Research & Development
21.6430.0538.6723.1418.0316.09
Upgrade
Operating Expenses
37.4342.125235.1326.1122.39
Upgrade
Operating Income
-37.34-42.12-51.92-34.1-24.96-22.39
Upgrade
Interest & Investment Income
2.743.883.11.090.190.18
Upgrade
Pretax Income
-34.6-38.24-48.82-33.02-24.77-22.22
Upgrade
Net Income
-34.6-38.24-48.82-33.02-24.77-22.22
Upgrade
Preferred Dividends & Other Adjustments
-----0
Upgrade
Net Income to Common
-34.6-38.24-48.82-33.02-24.77-22.22
Upgrade
Shares Outstanding (Basic)
313027242112
Upgrade
Shares Outstanding (Diluted)
313027242112
Upgrade
Shares Change (YoY)
7.11%13.03%10.20%17.37%69.51%143.87%
Upgrade
EPS (Basic)
-1.11-1.27-1.83-1.37-1.20-1.83
Upgrade
EPS (Diluted)
-1.11-1.27-1.83-1.37-1.20-1.83
Upgrade
Free Cash Flow
-25.04-33.08-47.498.28-21-21.87
Upgrade
Free Cash Flow Per Share
-0.80-1.10-1.780.34-1.02-1.80
Upgrade
Gross Margin
100.00%-100.00%100.00%100.00%-
Upgrade
Operating Margin
-41486.67%--64098.76%-3311.07%-2182.17%-
Upgrade
Profit Margin
-38443.33%--60269.14%-3205.53%-2165.56%-
Upgrade
Free Cash Flow Margin
-27824.44%--58627.16%803.69%-1835.58%-
Upgrade
EBITDA
-37.12-41.91-51.71-33.9-24.78-22.26
Upgrade
D&A For EBITDA
0.220.210.210.210.190.14
Upgrade
EBIT
-37.34-42.12-51.92-34.1-24.96-22.39
Upgrade
Revenue as Reported
0.09-0.081.031.14-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.